Mackay Shields LLC Arvinas, Inc. Transaction History

Mackay Shields LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$60.45 - $84.26 $574,275 - $800,470	-9,500 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$58.19 - $91.37 $366,597 - $575,631	-6,300 Reduced 39.87%	9,500 $628,000
Q4 2020 Feb 16, 2021	BUY	$20.19 - $84.93 $319,002 - $1.34 Million	15,800 New	15,800 $1.34 Million
Q2 2020 Jul 31, 2020	SELL	$29.88 - $56.74 $197,208 - $374,484	-6,600 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$33.0 - $54.5 $217,800 - $359,700	6,600 New	6,600 $266,000

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $990M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.